Mounjaro, a weight loss drug launched by Eli Lilly in India, could be a game-changer and has been making waves lately. Here's ...

The 76-year-old Oscar winner got serious about her health following her diagnosis for type 2 diabetes in 2017, but there was ...

Work is continuing so that the drug, and similar medicines, can be issued under medical card schemes to slash costs.

The European Medicines Agency (EMA) has advised that the drug can be used together with diet and physical activity to help ...

The Kremlin confirmed Monday that Russian President Vladimir Putin has gifted to Donald Trump a portrait he commissioned of ...

And, for what it’s worth, there is some data to suggest yerba mate may be associated with losing weight: It stimulates lipolysis, the breakdown of fats, according to 2019 research in the Brazilian ...

Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Obesity “wonder drug” Wegovy is expected to be on sale in Ireland in the next 10 days but, even now, the woman charged with overseeing new product launches of the drug’s developer, Novo ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...